These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3438644

  • 1. Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis.
    Marc-Aurele J, Caille G, Bourgoin J.
    Sleep; 1987; 10 Suppl 1():22-6. PubMed ID: 3438644
    [Abstract] [Full Text] [Related]

  • 2. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.
    Viron B, De Meyer M, Le Liboux A, Frydman A, Maillard F, Mignon F, Gaillot J.
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():95-104. PubMed ID: 2387982
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N, Lau H, Kong L, Kumar G, Zeldis JB, Knight R, Laskin OL.
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J, Heusse D, Hougton GW, Marc Aurele J, Dreyfus JF.
    Int Pharmacopsychiatry; 1982 Dec; 17 Suppl 2():76-91. PubMed ID: 7188377
    [Abstract] [Full Text] [Related]

  • 9. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE.
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of oral cefatrizine in patients with impaired renal function.
    Couet W, Fauvel JP, Laville M, Pozet N, Fourtillan JB.
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
    Pappas P, Karavasilis V, Briasoulis E, Pavlidis N, Marselos M.
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):358-60. PubMed ID: 15883819
    [Abstract] [Full Text] [Related]

  • 12. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G, Gajjar D, Swan S, Marbury T, Grasela DM, Wang Z.
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [Abstract] [Full Text] [Related]

  • 13. A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane).
    Houghton GW, Dennis MJ, Templeton R, Martin BK.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):97-100. PubMed ID: 3988401
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD.
    Kowalsky SF, Echols M, Schwartz MT, Bailie GR, McCormick E.
    Clin Nephrol; 1993 Jan; 39(1):53-8. PubMed ID: 8428409
    [Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A, Rius Alarcó F, García Díez JM, Mahiques E, Domingo JV.
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [Abstract] [Full Text] [Related]

  • 17. Colchicine disposition in patients with familial Mediterranean fever with renal impairment.
    Ben-Chetrit E, Scherrmann JM, Zylber-Katz E, Levy M.
    J Rheumatol; 1994 Apr; 21(4):710-3. PubMed ID: 8035398
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of ofloxacin in severe chronic renal failure.
    Bandai H, Tsubakihara Y, Yamato E, Yokoyama K, Okada N, Nakanishi I, Iida N.
    Clin Ther; 1989 Apr; 11(2):210-8. PubMed ID: 2736567
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of ibopamine in patients with renal impairment.
    Salvadeo A, Villa G, Bovio G, Pocchiari F, Pataccini R, Longo A, Ventresca GP.
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):98-104. PubMed ID: 3410592
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacokinetics of zopiclone.
    Fernandez C, Martin C, Gimenez F, Farinotti R.
    Clin Pharmacokinet; 1995 Dec; 29(6):431-41. PubMed ID: 8787948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.